Human asymptomatic Ebola infection and strong inflammatory response.
about
High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in GabonA novel rhabdovirus associated with acute hemorrhagic fever in central AfricaHuman fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosisTransmission dynamics and control of Ebola virus disease (EVD): a reviewIntracellular events and cell fate in filovirus infectionEbola virus antibody prevalence in dogs and human riskFilovirus research in Gabon and equatorial Africa: the experience of a research center in the heart of AfricaPotential Impact of Sexual Transmission on Ebola Virus Epidemiology: Sierra Leone as a Case StudyEbola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cellsGene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.Presence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic ReviewThe Role of Cytokines and Chemokines in Filovirus InfectionFiloviruses: One of These Things is (not) Like the OtherEbola: a holistic approach is required to achieve effective management and controlLujo viral hemorrhagic fever: considering diagnostic capacity and preparedness in the wake of recent Ebola and Zika virus outbreaksNeutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against itStructure of the Ebola virus glycoprotein bound to an antibody from a human survivorMarburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon AntagonismEbolavirus VP35 Coats the Backbone of Double-Stranded RNA for Interferon Antagonism[Haemostasis dysregulation in filovirus infections].Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivityEbola: translational science considerationsTransmission of Ebola viruses: what we know and what we do not knowUnderstanding ebola virus transmissionEarly immune responses accompanying human asymptomatic Ebola infectionsDiagnosis of Ebola Virus Disease: Past, Present, and FutureRisk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysisCirculating microRNA profiles of Ebola virus infectionTransmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic InfectionExperimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in GuineaProduction of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal CattleClinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, GuineaWhat is Ebola?Progress towards the treatment of Ebola haemorrhagic fever.The impact of control strategies and behavioural changes on the elimination of Ebola from Lofa County, LiberiaEvaluating the frequency of asymptomatic Ebola virus infectionEbola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.Emerging viral threats to the Australian blood supply.Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to Child.Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study.
P2860
Q21090030-22EEE8CE-A28A-42F1-AA27-883C654AF5CBQ21090485-337C21BA-34CE-40D7-9C2D-1B565A128302Q21144780-6B9E42C5-5F2E-4BC6-A944-A1315236D411Q21146685-BFAA96D9-FD11-4F02-AE52-DBD98BD5FA84Q22305521-1E80FF91-C216-44E3-9B14-C2E0C2052D2FQ22305651-1D3AAAA1-2C6F-42BE-B49E-915032DD4CD6Q24273305-A175F008-90E7-4B86-B381-FB7A4AD9DC77Q24288740-3806E835-E5D4-45E9-93BB-B3231C49FB32Q24794365-18EA10A2-AC95-45D9-91AF-834BFC8FD4BFQ25256700-0FBEDD27-036E-4E2E-A650-2E69A65A6E64Q26765404-2F0922BB-5E57-45CF-B798-DDBA9E0F5F0AQ26778003-72861122-1C1D-486E-8B62-30F5E0F7D08CQ26783063-A98DA65B-D3B8-475D-8A55-078D6B7086DEQ26823792-555D4CF7-7AFA-4FE0-9EAC-8051B83D70FBQ27010420-3ED8F527-D8FF-4304-B96D-B0908C5943EAQ27489891-2BA67E7E-B20C-4F6B-8D55-D7B9CA8589CCQ27651112-88DD2A87-57A1-4E33-B04E-A515A4C6803EQ27673907-9D77FC20-6248-49FE-8FB2-543734306927Q27678917-A52CE2D8-E0F0-48F4-A9D4-E8B76A32D3B4Q27691452-27CD00B1-C19B-406B-922D-80D5D02E5D7EQ28066142-2FC3FD10-0567-43F8-923F-393F673E904DQ28082994-05384F35-F5A4-4759-8D3C-932591458BB9Q28083565-6CF10DF2-852C-49B0-9D3E-4EAEC3BA7D72Q28088529-BF2FB988-01E4-4BAA-A592-780A91FE6704Q28344889-7BA756CD-A6A3-46EE-84C7-1552C7629EA0Q28388534-C013E32E-9E26-42AB-85C1-B435B5CA7C71Q28389947-5429C85B-FBBD-4824-B30F-978BBE7286BBQ28392668-750BC9C7-E502-465B-BCB1-A2E3F7CFEBF0Q28393073-E25EF6B8-26E1-4038-BE0F-099CA82AB39AQ28550455-22145BE7-78F6-42F9-B060-3CE5AF1B8811Q28603849-EF016396-05F9-487A-A60A-9FDCE94D30A3Q29247868-AD3555AE-4AC6-4C52-A31E-C410BC446D2DQ30205723-82830F6A-D3B6-41DB-8E0B-8343982F8290Q30230272-3972CA9F-7C1A-4BBF-B50E-D03035E828DFQ30251097-B8740E50-A2C2-4458-B2BC-6AF4FCD01508Q30251098-6C33D7C2-537A-45FA-BDD2-14DCBBB629F9Q30251949-3D167D97-EC69-4A7E-B7BC-56A2AD3E61C1Q33368262-48CC418C-0D3E-4D63-AEB8-6C1FFE9FF81BQ33603036-C8D5A329-DD8A-4821-A4DA-0917412532D5Q33693686-7D60DF6F-670C-4C2B-A99C-2179B443E021
P2860
Human asymptomatic Ebola infection and strong inflammatory response.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Human asymptomatic Ebola infection and strong inflammatory response.
@ast
Human asymptomatic Ebola infection and strong inflammatory response.
@en
type
label
Human asymptomatic Ebola infection and strong inflammatory response.
@ast
Human asymptomatic Ebola infection and strong inflammatory response.
@en
prefLabel
Human asymptomatic Ebola infection and strong inflammatory response.
@ast
Human asymptomatic Ebola infection and strong inflammatory response.
@en
P2093
P50
P1433
P1476
Human asymptomatic Ebola infection and strong inflammatory response.
@en
P2093
A J Georges
J B McCormick
J Lansoud-Soukate
M C Georges-Courbot
S P Fisher-Hoch
V E Volchkov
P304
P356
10.1016/S0140-6736(00)02405-3
P407
P577
2000-06-01T00:00:00Z